Company: IMNN
Filing Date: 2025-06-09
Form Type: DEF 14A
Source: 0001641172-25-014324
Chunk: 45

Company: Imunon, Inc.
Filing Date: 2025-06-09
Form: DEF 14A
Chunk 45
---
 ACCOUNTING FIRM FOR THE COMPANY FOR THE YEAR ENDING DECEMBER 31, 2025.</div>

| 37 |

<div align='center'>PROPOSAL NO. 3:

ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</div>

The Company is providing its stockholders with the opportunity to cast a non-binding, advisory vote on the compensation of our Named Executive Officers as disclosed pursuant to the SEC’s executive compensation disclosure rules and set forth in this proxy statement (including in the compensation tables and narratives accompanying those tables).

Our executive compensation program is guided by the principle that the compensation of the Company’s executive officers should encourage the creation of stockholder value and achievement of strategic corporate objectives. In furtherance of this principle, the Company’s executive compensation program includes a number of features intended to reflect best practices in the market and help ensure that the program reinforces stockholder interests. These features include the following:

| ● | A                                                                                                                                  
 significant amount of the executives’ compensation is at risk. For fiscal year 2024, Approximately 30% of Dr. Lindborg’s           
 target total direct compensation was performance-based and/or linked to the value of the Company’s stock price.                    |
| ● | Executives’                                                                                                                        
 bonuses under our annual incentive program are principally based on the achievement of specific performance objectives established 
 at the beginning of the fiscal year by the Compensation Committee.                                                                 |
| ● | Executives’                                                                                                                        
 equity awards are granted in the form of stock options that help to align the executives’ interests with those of our stockholders 
 as the options will not have value unless there is appreciation in the Company’s stock price after the option is granted.          |

In accordance with the requirements of Section 14A of the Exchange Act (which was added by the Dodd-Frank Wall Street Reform and Consumer Protection Act) and the related rules of the SEC, the Board of Directors will request your advisory vote on the following resolution at the Annual Meeting:

RESOLVED,that the compensation paid to the Company’s Named Executive Officers, as disclosed in this proxy statement pursuant to the SEC’s executive compensation disclosure rules (which disclosure includes the compensation tables and the narrative discussion that accompanies the compensation tables), is hereby approved.

This vote is an advisory vote only and is non-binding on the Company, the Board of Directors or the Compensation Committee, and will not be construed as overruling a decision by, or creating or implying any additional fiduciary duty for, the Board of Directors or